SCHEMBL7950385

SCHEMBL7950385

Fc1ccccc1C1=NCC(=S)Nc2ccc(I)cc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 13/20 1.00
ALOX12 P18054 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
GABRA1 P14867 1/20 0.53
GABRA5 P31644 1/20 0.53
GABRA3 P34903 1/20 0.53
GABRA2 P47869 1/20 0.53
GABRB2 P47870 1/20 0.53
LMNA P02545 1/20 0.53
ALDH1A1 P00352 1/20 0.50
PKM P14618 1/20 0.50
HTT P42858 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
PTAFR P25105 1/20 0.48
CHRM5 P08912 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23881527 0.87 CHRM1 (0.77) CHRM1ALOX12SMN1; SMN2GABRA1GABRA5
SCHEMBL7324382 0.87 CHRM1 (0.77) CHRM1ALOX12SMN1; SMN2GABRA1GABRA5
SCHEMBL11733109 0.85 CHRM1 (0.73) CHRM1ALOX12SMN1; SMN2GABRA1GABRA5
SCHEMBL7318175 0.85 GABRA1 (0.73) CHRM1GABRA1GABRA5GABRA3GABRA2
SCHEMBL7328311 0.85 CHRM1 (1.00) CHRM1ALOX12SMN1; SMN2GABRA1GABRA5
SCHEMBL7324283 0.85 CHRM1 (0.73) CHRM1ALOX12SMN1; SMN2GABRA1GABRA5
SCHEMBL30320323 0.85 CHRM1 (1.00) CHRM1ALOX12SMN1; SMN2GABRA1GABRA5
SCHEMBL10741591 0.83 CHRM1 (0.71) CHRM1ALOX12SMN1; SMN2GABRA1GABRA5
SCHEMBL11825759 0.82 CHRM1 (0.74) CHRM1ALOX12SMN1; SMN2GABRA1GABRA5
SCHEMBL8933625 0.81 CHRM1 (0.69) CHRM1ALOX12SMN1; SMN2GABRA1GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6174881-B1 USED AS ANXIOLYTIC AND/OR ANTICONVULSANT AND/OR MUSCLE RELAXANT AGENTS; SEDATIVES OR HYPNOSIS; WATER-SOLUBLE AMINE SALTS; FAST-ACTING HOFFMAN-LA ROCHE INC. 2001-01-16 US disclosed
EP-0320992-B1 Triazolodiazepine derivatives HOFFMANN LA ROCHE (CH) 1994-07-27 EP disclosed
US-4959361-A Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists HOFFMANN-LA ROCHE INC. (US) 1990-09-25 US disclosed